Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.

Test time has arrived: the first person has been treated in a highly anticipated gene therapy trial that aims to coax aged ...

To determine the therapeutic efficacy of in vivo reprogramming of astrocytes into neuronal-like cells in animal models of spinal cord injury (SCI). PRISMA 2020 guidelines were utilized, and search ...

Now he has a company that is trying to change the way we think about the so-called dark genome or noncoding DNA. Previously ...

Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...

World’s first anti-ageing gene therapy trial begins as ER-100 is injected into a human eye, testing partial cellular ...

The approach relies on “reprogramming” cells to a younger state. It’s one of many strategies being explored by biotech ...

Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in pancreatic cancer—and identified a promising strategy to overcome that resistance.

Leuven, 11 March 2025 – Solid tumors often provide a challenging environment for the T cells of our immune system. By reprogramming the metabolism of T cells, scientists at the VIB-KU Leuven Center ...

A team of health and medical researchers affiliated with a host of institutions across Sweden has tested the possibility of reprogramming cancer cells into cDC1 cells as a means for destroying the ...

Harvard Stem Cell Institute (HSCI) researchers, representing five Harvard departments and affiliated institutions as well as the Massachusetts Institute of Technology (MIT), have demonstrated that ...